Sanofi-aventis
RSS
Cheap malaria pills to cut deaths in Africa
Mar 2 2007, Anupam Agnihotri

Now fight against malaria would be cheaper than ever before. Thanks to the partnership of international medicine, giant Sanofi-Aventis and a medical charity known as Drugs for Neglected Diseases Initiative that has made the advent of this cheap...

Related Stories
Most Recent Most Popular Most Commented
(0)
Sanofi-Aventis to buy US-based BiPar Sciences
AP, Paris
Sanofi-Aventis SA has agreed to pay up to $500 million to buy California-based BiPar Sciences in a move to strengthen its research and development in cancer treatments,...
EU, France, Sanofi, Aventis
made popular Apr 15 2009
(0)
FDA panel backs Sanofi drug to treat heart rhythms
AP, Washington
A panel of cardiology experts recommends that an experimental drug from Sanofi-Aventis be approved to treat irregular heart rhythms linked to stroke.
Sanofi, FDA, Panel, Business
made popular Mar 18 2009
(0)
FDA favors approval for Sanofi heart drug
AP, Washington
The Food and Drug Administration says an experimental drug from Sanofi-Aventis could significantly decrease hospitalizations caused by irregular heart rhythms.
FDA, Review, Sanofi, Business
made popular Mar 16 2009
(0)
Sanofi-Aventis 4Q profit sinks 76 pct on charge
AP, Paris
Drug maker Sanofi-Aventis SA said Wednesday its fourth quarter net profit plummeted 76 percent from a year earlier due mainly to a charge taken for discontinuing two...
EU, France, Earns, Sanofi
made popular Feb 11 2009
(0)
Sanofi-Aventis announces management shuffle
AP, Paris
Sanofi-Aventis SA said Wednesday that its top legal and financial officer has stepped down, and that two executives will inherit each of his former roles at the French...
EU, France, Sanofi, Aventis
made popular Dec 10 2008
(0)
Sanofi-Aventis to cut US sales jobs
AP, New York
French drugmaker Sanofi-Aventis SA is cutting an unspecified number of U.S. sales jobs as part of a realignment of its marketing.
Sanofi, Aventis, Job, Cuts
made popular Dec 4 2008
(0)
Sanofi-Aventis settles patent infringement cases
AP, Paris
Sanofi-Aventis SA said Wednesday it has settled lawsuits against rival drugmakers it accused of infringing on its patents in the United States with their generic...
EU, France, Sanofi, Aventis
made popular Nov 19 2008
(0)
Sanofi-Aventis ends research on troubled diet drug
AP, Trenton
French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.
Sanofi, Aventis, Diet, Drug
made popular Nov 5 2008
(0)
Sanofi best-sellers help lift net profit in 3Q
AP, Paris
French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net profit by 1.9...
EU, France, Earns, Sanofi
made popular Oct 31 2008
(0)
Sanofi best-sellers help lift core earnings in 3Q
AP, Paris
French pharmaceutical giant Sanofi-Aventis said Friday higher sales of its most widely prescribed treatments helped lift its core earnings in the third quarter.
EU, France, Earns, Sanofi
made popular Oct 31 2008
(0)
Sanofi-Aventis suspends Acomplia sales in Europe
AP, Paris
French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities...
Sanofi, Aventis, Obesity, Drug
made popular Oct 23 2008
(0)
Sanofi names Viehbacher as new CEO
AP, Paris
Sanofi-Aventis named former GlaxoSmithKline executive Chris Viehbacher as new chief executive in a move aimed at redefining its strategy, the French drugmaker said...
France, Sanofi, Aventis, Business
made popular Sep 10 2008
(0)
Sanofi-Aventis Developing New Drugs
AP, Paris
Sanofi-Aventis SA expects to make 31 submissions for new drugs by the end of 2010, the world’s third largest drugmaker announced Monday.In its first such update...
Europe, NorthAmerica, France, United States
made popular Sep 17 2007
All Stories
Most Recent Most Popular Most Commented
(0)
FDA panel backs Sanofi drug to treat heart rhythms
AP, Washington
A panel of cardiology experts recommends that an experimental drug from Sanofi-Aventis be approved to treat irregular heart rhythms linked to stroke.
Sanofi, FDA, Panel, Business
made popular Mar 18 2009
(0)
FDA favors approval for Sanofi heart drug
AP, Washington
The Food and Drug Administration says an experimental drug from Sanofi-Aventis could significantly decrease hospitalizations caused by irregular heart rhythms.
FDA, Review, Sanofi, Business
made popular Mar 16 2009
(0)
Sanofi-Aventis, Pfizer end studies on 2 diet drugs
AP, Trenton
French drugmaker Sanofi-Aventis said Wednesday it is halting all research on a diet drug sold in Europe, Acomplia, and rival Pfizer Inc. hours later said it is ending...
Failed, Diet, Drugs, Business
made popular Nov 5 2008
(0)
Sanofi-Aventis ends research on troubled diet drug
AP, Trenton
French drugmaker Sanofi-Aventis is halting all research on a once-promising diet drug that never made it to the U.S. market.
Sanofi, Aventis, Diet, Drug
made popular Nov 5 2008
(0)
Sanofi best-sellers help lift net profit in 3Q
AP, Paris
French pharmaceutical giant Sanofi-Aventis said Friday that higher sales of blood thinners Lovenox and Plavix and diabetes treament Lantus helped lift net profit by 1.9...
EU, France, Earns, Sanofi
made popular Oct 31 2008
(0)
Sanofi best-sellers help lift core earnings in 3Q
AP, Paris
French pharmaceutical giant Sanofi-Aventis said Friday higher sales of its most widely prescribed treatments helped lift its core earnings in the third quarter.
EU, France, Earns, Sanofi
made popular Oct 31 2008
(0)
Sanofi-Aventis suspends Acomplia sales in Europe
AP, Paris
French pharmaceutical company Sanofi-Aventis temporarily suspended sales of anti-obesity drug Acomplia in Europe, the company said Thursday, after health authorities...
Sanofi, Aventis, Obesity, Drug
made popular Oct 23 2008
(0)
Sanofi names Viehbacher as new CEO
AP, Paris
Sanofi-Aventis named former GlaxoSmithKline executive Chris Viehbacher as new chief executive in a move aimed at redefining its strategy, the French drugmaker said...
France, Sanofi, Aventis, Business
made popular Sep 10 2008
(0)
Ambien makers switch to defensive mode
Puja, New-Delhi
All the sleeping medications are now shifting their focus to a great extent to vital safety factor. In order to stick to the factor more attention towards safety has...
Ambien Safety, Sepracor, Sanofi-Aventis, Business
made popular Apr 13 2006
(0)
Fake Anti-obesity Drug Touted on Internet: EU Warns
Irani, New Delhi
Be aware of fake anti-obesity drugs in the market. Fake versions of an anti-obesity drug are being touted on the Internet even though European Union has not approved it...
Fake Anti-obesity Drug, Anti-obesity Drug, Anti-obesity, rimonabant
made popular Mar 28 2006
(0)
Obesity Drug Sales May Be More Than $1.7B by 2014!
Irani, New Delhi
Sales of obesity drugs may reach to more than $1.7 billion by 2014. An analyst firm predicts in a new report that it is the launch of obesity drugs from three...
Obesity Drug, pharmaceutical companies, Sanofi-aventis, Accomplia
made popular Mar 23 2006
Related Tags
Acomplia aventis Business diet Drug Drug Administration earns EU Europe FDA France French Health & Fitness North America Panel Paris sanofi trenton United States Washington
FAQ / Help
Move to top